Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Long-Term Investments (2019 - 2025)

Phibro Animal Health (PAHC) has 8 years of Long-Term Investments data on record, last reported at $367000.0 in Q4 2025.

  • For Q4 2025, Long-Term Investments fell 94.26% year-over-year to $367000.0; the TTM value through Dec 2025 reached $367000.0, down 94.26%, while the annual FY2025 figure was $5.1 million, 18.45% down from the prior year.
  • Long-Term Investments reached $367000.0 in Q4 2025 per PAHC's latest filing, up from $42000.0 in the prior quarter.
  • Across five years, Long-Term Investments topped out at $16.5 million in Q3 2022 and bottomed at $42000.0 in Q3 2025.
  • Average Long-Term Investments over 5 years is $5.9 million, with a median of $6.0 million recorded in 2022.
  • Peak YoY movement for Long-Term Investments: surged 144.3% in 2023, then crashed 99.34% in 2025.
  • A 5-year view of Long-Term Investments shows it stood at $4.7 million in 2021, then rose by 7.19% to $5.1 million in 2022, then fell by 13.33% to $4.4 million in 2023, then surged by 45.94% to $6.4 million in 2024, then tumbled by 94.26% to $367000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Investments were $367000.0 in Q4 2025, $42000.0 in Q3 2025, and $5.1 million in Q2 2025.